About CLINUVEL

Mr Stanley McLiesh

BEd

Non-Executive Chair

 

Mr McLiesh has vast experience in commercializing pharmaceutical products internationally.

As the former General Manager, Pharmaceuticals at CSL Limited, he was closely involved in the transition of CSL from government ownership through corporatisation to a highly successful listed company. While at CSL, Mr McLiesh brokered numerous in-licensing agreements with international companies enabling CSL to expand into new markets profitably.

He has also been closely involved in a number of M&A transactions, the establishment of partnerships and collaborative relationships while he was the key professional to negotiate supply agreements for CSL's export products to international markets.

Mr McLiesh was formerly a non executive director of Unilife Medical Solutions Ltd. His considerable experience in the international pharmaceutical industry benefits CLINUVEL's international strategies.

In the latter stages of the development program Mr McLiesh is involved in formulating the commercial phase of CLINUVEL.

Latest Company Announcements

07 December 2017

CLINUVEL Newsletter - December 2017

The CLINUVEL team is looking with much optimism and energy to the start of 2018.

Read More
05 December 2017

Lapse and Forfeit of Unlisted Conditional Performance Rights

Lapse and Forfeit of Unlisted Conditional Performance Rights

Read More
05 December 2017

Appendix 3Z - Final Director’s Interest Notice

Final Director’s Interest Notice

Read More
27 November 2017

Chair's Address to the Annual General Meeting

Coming from the background of an ethical pharmaceutical company I had some misgivings 15 years ago of joining the board of a company with a ‘tanning’ drug.

Read More
27 November 2017

Managing Director's AGM Presentation

AGM Presentation

Read More
27 November 2017

Results of Meeting

AGM results

Read More

Quick Links